State of the art in mitral valve replacement Dr. Ted Feldman, Dr. Mayra Guerrero and Dr. C. Michael Gibson Discuss

Sildenafil in patients with corrected valvular heart disease and PH Dr. Javier Bermejo and Dr. C. Michael Gibson Discuss

Gender Differences in Outcomes With TAVR Women Undergoing TAVR are at a Decreased Risk of Long-term Mortality

In a recent meta-analysis published in the Journal of the American College of Cardiology, it was found that postoperative complications of Transcatheter Aortic Valve Replacement (TAVR) were different between males and females. While females were at increased risk of short-term complications (within 30 days) such as bleeding, stroke, and vascular complications, they had a lower incidence all-cause mortality within one year of the procedure. Continue reading →

Mechanically Expanded vs Self-Expanding TAVR in AS Mechanically Expanded Valves May be a Useful Addition for TAVR

The use of mechanically expandable valves was not inferior to self-expandable valves in high risk patients with severe aortic stenosis enrolled in the REPRISE III clinical trial. The trial results support the potential for the first generation LOTUS valve to become part of regular clinical practice. Continue reading →